Clinical trials: COVID19 Patients
Infectious Disease
Effectiveness of Convalescent Plasma Therapy in 8 Non-Intubated COVID-19 Patients in Indonesia: A Case Series
This is the first Case Studies article highlight factors determine the effectiveness of Convalescent Plasma Therapy (CPT) in Indonesia, accompanied by supporting data and images before and after the patients received the therapy.
- Trial name
- NCT05046652
- Testing
- Convalescent Plasma Therapy
- Where
- Indonesia
- Volunteers
- 8 people
- Sponsor
- Maranatha Christian University
Coronavirus Disease (COVID-19), COVID-19
Retrospective Study on Severe Respiratory Illness to Access the Presence of COVID-19
Retrospective study from November 2019 -Febrauary 2020 on severe respiratory illness to access the presence or absence of COVID-19 in patients samples by real-time PcR
- Trial name
- Explore (NCT04346056)
- Where
- 2 sites in Egypt
- Volunteers
- 500 people
- Sponsor
- Ain Shams University
COVID-19
Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia
At present, no treatment has been approved for COVID-19. However, in light of the increased interest on using the anti-cytokine therapy targeting IL-6 tocilizumab in COVID-19 infected patients due to its potential benefit, the…
- Trial name
- NCT04445272
- Testing
- Tocilizumab
- Where
- 42 sites in Spain
- Volunteers
- 495 people
- Sponsor
- Fundacion SEIMC-GESIDA
COVID-19
Arrhythmias in Patients With COVID-19
The study is a prospective clinical cohort study of consecutive patients hospitalized at all hospitals of greater Copenhagen with a laboratory confirmed diagnosis of COVID-19.
- Trial name
- ACOVID (NCT04395664)
- Testing
- C3+ Holter Monitor
- Where
- Denmark
- Volunteers
- 1,000 people
- Sponsor
- Herlev and Gentofte Hospital
COVID, Kidney Transplant; Complications
Maintenance Versus Reduction of Immunosuppression for Renal Transplant Patients Hospitalized With COVID-19 Disease
This will be a randomized trial of maintenance versus reduction in immunosuppression in adult patients (age >18 years old) with functioning renal transplants admitted to hospital with confirmed COVID-19 disease.
- Conditions
- COVID, Kidney Transplant; Complications, Immunosuppression
- Trial name
- NCT04420364
- Testing
- Maintenance or reduction of immunosuppression
- Sponsor
- Brigham and Women's Hospital
SARS-CoV-2 Infection, Anti-SARS-CoV-2 Infection
Registry of Sustained Immunity to COVID-19 Among ESKD Patients
This is a multi-center, prospective registry study of subjects undergoing hemodialysis for treatment of end-stage renal disease in a DaVita center.
- Trial name
- RePAiR (NCT04495764)
- Where
- 12 sites in United States
- Volunteers
- 2,315 people
- Sponsor
- Davita Clinical Research
General Anesthesia, COVID-19
Postoperative Sugammadex After COVID-19
Researcher want to compare and evaluate the effect of sugammadex on postoperative recovery, with a focus on the occurrence of postoperative urinary dysfunction, in patients who have undergone regular abdominal surgery within a…
- Trial name
- NCT05817019
- Testing
- Sugammadex Sodium, neostigmine 50µg/kg + glycopyrollate 0.01mg/kg
- Volunteers
- 300 people
- Sponsor
- Korea University Ansan Hospital
COVID-19
COVID-19 Antithrombotic Rivaroxaban Evaluation
There are several ways in which the COVID-19 pandemic may affect the prevention and management of thrombotic and thromboembolic disease, either direct effect or the indirect effects of infection, such as through severe illness…
- Trial name
- CARE (NCT04757857)
- Testing
- Rivaroxaban 10 mg
- Where
- 36 sites in Brazil
- Volunteers
- 660 people
- Sponsor
- Hospital Alemão Oswaldo Cruz
COPD Patients and Patients Recovering From COVID19
Increasing Physical Activity in COPD Through Rhythmically Enhanced Music
The VA cares for nearly one million Veterans with COPD at a cost of more than $5.5 billion annually. COPD profoundly impairs quality of life as it limits ability to work, to maintain physical exertion and to engage in social…
- Trial name
- NCT03655028
- Testing
- rhythmically auditory stimulation enhanced music, control
- Where
- United States
- Volunteers
- 93 people
- Sponsor
- VA Office of Research and Development
SARS CoV 2 Infection, Muscle Disorder
Eficacia Ventilatoria y Remolacha
The lung is the organ most affected by COVID-19. There are patients who successfully overcome the acute COVID-19 infection and their lungs return to a normal state.
- Conditions
- SARS CoV 2 Infection, Muscle Disorder, Fatigue
- Trial name
- NCT06217211
- Testing
- Remolacha
- Where
- Spain
- Volunteers
- 30 people
- Sponsor
- Hospital de Mataró
COVID, Embolism and Thrombosis
COVID-19, bLOod Coagulation and Thrombosis
Coronavirus 2 (SARS-CoV2) has been identified as the pathogen responsible for severe acute respiratory syndrome associated with severe inflammatory syndrome and pneumonia (COVID-19).
- Conditions
- COVID, Embolism and Thrombosis, Pneumonia, Viral
- Trial name
- CLOT (NCT04388657)
- Testing
- Echo-Doppler
- Where
- 3 sites in France
- Volunteers
- 100 people
- Sponsor
- GCS Ramsay Santé pour l'Enseignement et la Recherche
COVID-19, Corona Virus Infection
Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care
This study will assess the efficacy of hydroxychloroquine in reducing the severity of symptoms in patients with COVID-19
- Conditions
- COVID-19, Corona Virus Infection, SARS-CoV-2, 2019-nCoV
- Trial name
- NCT04334967
- Testing
- Hydroxychloroquine, Vitamin C
- Where
- United States
- Volunteers
- 13 people
- Sponsor
- Providence Health & Services
COVID-19 Pneumonia
Tocilizumab in COVID-19 Pneumonia (TOCIVID-19)
This study project includes a single-arm phase 2 study and a parallel cohort study, enrolling patients with COVID-19 pneumonia.
- Trial name
- TOCIVID-19 (NCT04317092)
- Testing
- Tocilizumab Injection
- Where
- 27 sites in Italy
- Volunteers
- 402 people
- Sponsor
- National Cancer Institute, Naples
Severe COVID-19
Effect of Traditional Chinese Medicine of Severe COVID-19
This study evaluated the effect of integrated traditional Chinese and Western medicine in the treatment of Severe COVID-19. The patients were randomly divided into experimental group and control group.
- Trial name
- COVID-19 (NCT06714032)
- Testing
- TCM plus conventional drug
- Where
- China
- Volunteers
- 172 people
- Sponsor
- Henan University of Traditional Chinese Medicine
COVID-19, SARS-CoV-2 Infection
Evaluation of the Efficacy and Safety of Molnupiravir Treatment in Mild/Moderate Covid-19 Patients.
Evaluation of the Efficacy and Safety of Molnupiravir Treatment in Mild/Moderate Covid-19 Patients. Turkey Cohort, Prospective, Observational, Comparative Study In the antiviral treatment of COVID-19, molnupiravir, an RdRp…
- Trial name
- NCT06223932
- Testing
- Molnupiravir
- Where
- 8 sites in Turkey (Türkiye)
- Volunteers
- 2,600 people
- Sponsor
- Serap Yavuz
Allergy and Immunology, Infection Viral
Evaluation of Immune Response in COVID-19 Patients
The aim of the project is to evaluate the immunological features of COVID-19 patients. Patients are recruited without any pharmacological treatments restriction.
- Trial name
- IMMUNOVID (NCT04438629)
- Testing
- COVID-19 treatment
- Where
- Italy
- Volunteers
- 80 people
- Sponsor
- Azienda Ospedaliera Universitaria Integrata Verona
Covid19, Rehabilitation
Tele-coaching in Patients With COVID-19
Respiratory exercise training and aerobic exercise training will be given to patients who have been hospitalized in intensive care due to COVID 19 and underwent IMV, who were hospitalized in the service and underwent NIMV or…
- Trial name
- NCT04791072
- Testing
- Exercise
- Volunteers
- 36 people
- Sponsor
- Izmir Katip Celebi University
Schizophrenia
The Impact of the Covid-19 Pandemic on Schizophrenia Patients Registered With the Community Mental Health Center
This study aimed to examine the effect of the Covid-19 pandemic on schizophrenia patients registered to the Community Mental Health Center (CMHC) in terms of depression, suicide risk, and tendency to violence.
- Trial name
- NCT05109572
- Testing
- Hospitalized, Non-hospitalized with emergency care, Non-hospitalized and non-emergency care
- Where
- Turkey (Türkiye)
- Volunteers
- 108 people
- Sponsor
- Dr. Lutfi Kirdar Kartal Training and Research Hospital
COVID-19
Eosinophil and Anticoagulation in COVID-19 Patients
Despite prophylactic anticoagulant treatments, thrombotic complications may develop in patients with Coronavirus disease 2019 (COVID-19).
- Trial name
- NCT04507282
- Testing
- LMWH
- Where
- Turkey (Türkiye)
- Volunteers
- 80 people
- Sponsor
- Bursa Postgraduate Hospital
COVID-19
Impact of COVID-19 Outbreak on Non-COVID-19 Patients
The Geneva Canton organized the health crisis of the COVID-19 epidemic around the care of COVID patients at the University Hospital (HUG), by moving the care of non-COVID patients to private hospitals of the canton.
- Trial name
- NoCOVImpact (NCT04537559)
- Where
- Switzerland
- Volunteers
- 240,000 people
- Sponsor
- University Hospital, Geneva
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.